TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
FTRE

Fortrea Holdings Inc.

Healthcare · Biotechnology

19.90$ -0.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Fortrea Holdings Inc. (FTRE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 678 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement FTRE
Line item Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
779 793 762 503 694 725 714 775 662 662 675 697 651 710 701 661 637 678 2,677
662 638 595 218 542 569 564 656 554 525 527 556 535 596 598 549 533 539 2,219
117 155 168 284 152 156 150 120 108 137 148 141 117 114 103 112 104 139 458
– 71 71 83 80 81 79 99 120 156 136 148 122 125 107 103 101 102 412
75 71 99 293 138 125 140 130 145 188 166 197 637 125 119 103 101 124 447
42 84 69 -8.3 14 32 10 -11 -37 -51 -18 -56 -520 -11 -16 8.8 3.3 15 11
– 0.0 0.0 0.2 33 0.7 35 35 34 45 22 22 22 23 23 23 19 19 84
38 84 74 -8.3 9.5 37 -22 -41 -76 -89 -36 -75 -548 -371 -29 -36 -12 -1.2 -78
5.0 17 14 5.3 1.5 12 -5.8 -5.0 4.1 11 -17 -1.0 15 4.2 -13 -3.1 11 12 7.4
33 66 61 27 13 31 -14 -36 -101 -138 -28 -61 -563 -375 -16 -33 -24 -13 -85
68 111 97 4.9 38 63 38 17 -18 -22 7.8 -32 -506 -328 14 6.9 26 34 81

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?